126 related articles for article (PubMed ID: 28042103)
21. In vitro prediction of in vivo absorption of ibuprofen from suspensions through rational choice of dissolution conditions.
Hofmann M; García MA; Al-Gousous J; Ruiz-Picazo A; Thieringer F; Nguyen MA; Månsson W; Galle PR; Langguth P
Eur J Pharm Biopharm; 2020 Apr; 149():229-237. PubMed ID: 32112894
[TBL] [Abstract][Full Text] [Related]
22. Continuous twin-screw granulation for enhancing the dissolution of poorly water soluble drug.
Maniruzzaman M; Nair A; Renault M; Nandi U; Scoutaris N; Farnish R; Bradley MS; Snowden MJ; Douroumis D
Int J Pharm; 2015 Dec; 496(1):52-62. PubMed ID: 26387621
[TBL] [Abstract][Full Text] [Related]
23. Oral fast-dissolving drug delivery membranes prepared from electrospun polyvinylpyrrolidone ultrafine fibers.
Yu DG; Shen XX; Branford-White C; White K; Zhu LM; Bligh SW
Nanotechnology; 2009 Feb; 20(5):055104. PubMed ID: 19417335
[TBL] [Abstract][Full Text] [Related]
24. Taste-masking properties of solid lipid based micropellets obtained by cold extrusion-spheronization.
Petrovick GF; Breitkreutz J; Pein-Hackelbusch M
Int J Pharm; 2016 Jun; 506(1-2):361-70. PubMed ID: 27132502
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of taste-masking effects of pharmaceutical sweeteners with an electronic tongue system.
Choi du H; Kim NA; Nam TS; Lee S; Jeong SH
Drug Dev Ind Pharm; 2014 Mar; 40(3):308-17. PubMed ID: 23786206
[TBL] [Abstract][Full Text] [Related]
26. Tannate complexes of antihistaminic drug: sustained release and taste masking approaches.
Rahman Z; Zidan AS; Berendt RT; Khan MA
Int J Pharm; 2012 Jan; 422(1-2):91-100. PubMed ID: 22037447
[TBL] [Abstract][Full Text] [Related]
27. Bioequivalence of locally acting lozenges: Evaluation of critical in vivo parameters and first steps towards a bio-predictive in vitro test method.
Tietz K; Gutknecht SI; Klein S
Eur J Pharm Biopharm; 2018 Feb; 123():71-83. PubMed ID: 29170034
[TBL] [Abstract][Full Text] [Related]
28. Electronic tongue for the detection of taste-masking microencapsulation of active pharmaceutical substances.
Jańczyk M; Kutyła A; Sollohub K; Wosicka H; Cal K; Ciosek P
Bioelectrochemistry; 2010 Nov; 80(1):94-8. PubMed ID: 20869333
[TBL] [Abstract][Full Text] [Related]
29. Dissolution studies of metamizole sodium and pseudoephedrine sulphate dosage forms - comparison and correlation of electronic tongue results with reference studies.
Wesoły M; Zabadaj M; Cal K; Ciosek-Skibińska P; Wróblewski W
J Pharm Biomed Anal; 2018 Feb; 149():242-248. PubMed ID: 29127905
[TBL] [Abstract][Full Text] [Related]
30. The use of microviscometry to study polymer dissolution from solid dispersion drug delivery systems.
Esnaashari S; Javadzadeh Y; Batchelor HK; Conway BR
Int J Pharm; 2005 Mar; 292(1-2):227-30. PubMed ID: 15725569
[TBL] [Abstract][Full Text] [Related]
31. Enhancing the solubility and masking the bitter taste of propiverine using crystalline complex formation.
Ogata T; Tanaka D; Ozeki T
Drug Dev Ind Pharm; 2014 Aug; 40(8):1084-91. PubMed ID: 23789589
[TBL] [Abstract][Full Text] [Related]
32. Quantification of in situ granulation-induced changes in pre-compression, solubility, dose distribution and intrinsic in vitro release characteristics of ibuprofen-cationic dextran conjugate crystanules.
Abioye AO; Kola-Mustapha A; Chi GT; Ilya S
Int J Pharm; 2014 Aug; 471(1-2):453-77. PubMed ID: 24886691
[TBL] [Abstract][Full Text] [Related]
33. Raman spectroscopy as a process analytical technology tool for the understanding and the quantitative in-line monitoring of the homogenization process of a pharmaceutical suspension.
De Beer TR; Baeyens WR; Ouyang J; Vervaet C; Remon JP
Analyst; 2006 Oct; 131(10):1137-44. PubMed ID: 17003862
[TBL] [Abstract][Full Text] [Related]
34. Lean production of taste improved lipidic sodium benzoate formulations.
Eckert C; Pein M; Breitkreutz J
Eur J Pharm Biopharm; 2014 Oct; 88(2):455-61. PubMed ID: 24859305
[TBL] [Abstract][Full Text] [Related]
35. Influence of process parameters and equipment on dry foam formulation properties using indomethacin as model drug.
Sprunk A; Page S; Kleinebudde P
Int J Pharm; 2013 Oct; 455(1-2):189-96. PubMed ID: 23891743
[TBL] [Abstract][Full Text] [Related]
36. A discriminatory intrinsic dissolution study using UV area imaging analysis to gain additional insights into the dissolution behaviour of active pharmaceutical ingredients.
Hulse WL; Gray J; Forbes RT
Int J Pharm; 2012 Sep; 434(1-2):133-9. PubMed ID: 22626886
[TBL] [Abstract][Full Text] [Related]
37. Advanced stable lipid-based formulations for a patient-centric product design.
Becker K; Saurugger EM; Kienberger D; Lopes D; Haack D; Köberle M; Stehr M; Lochmann D; Zimmer A; Salar-Behzadi S
Int J Pharm; 2016 Jan; 497(1-2):136-49. PubMed ID: 26621689
[TBL] [Abstract][Full Text] [Related]
38. Formulation studies for mirtazapine orally disintegrating tablets.
Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Ünlü N
Drug Dev Ind Pharm; 2016; 42(6):1008-17. PubMed ID: 26530146
[TBL] [Abstract][Full Text] [Related]
39. A comparative study on two electronic tongues for pharmaceutical formulation development.
Woertz K; Tissen C; Kleinebudde P; Breitkreutz J
J Pharm Biomed Anal; 2011 May; 55(2):272-81. PubMed ID: 21353433
[TBL] [Abstract][Full Text] [Related]
40. Influence of Experimental Conditions on Electronic Tongue Results-Case of Valsartan Minitablets Dissolution.
Wesoły M; Kluk A; Sznitowska M; Ciosek P; Wróblewski W
Sensors (Basel); 2016 Aug; 16(9):. PubMed ID: 27563904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
